117 related articles for article (PubMed ID: 15312144)
1. Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury.
Bonato VL; Gonçalves ED; Soares EG; Santos Júnior RR; Sartori A; Coelho-Castelo AA; Silva CL
Immunology; 2004 Sep; 113(1):130-8. PubMed ID: 15312144
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
3. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
Wang QM; Kang L; Wang XH
Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
6. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.
Turner J; D'Souza CD; Pearl JE; Marietta P; Noel M; Frank AA; Appelberg R; Orme IM; Cooper AM
Am J Respir Cell Mol Biol; 2001 Feb; 24(2):203-9. PubMed ID: 11159055
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
8. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma.
Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A
Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611
[TBL] [Abstract][Full Text] [Related]
9. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology.
Watson VE; Hill LL; Owen-Schaub LB; Davis DW; McConkey DJ; Jagannath C; Hunter RL; Actor JK
J Pathol; 2000 Feb; 190(2):211-20. PubMed ID: 10657021
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice.
Teixeira FM; Teixeira HC; Ferreira AP; Rodrigues MF; Azevedo V; Macedo GC; Oliveira SC
Clin Vaccine Immunol; 2006 Aug; 13(8):930-5. PubMed ID: 16893994
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
13. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.
Ngai P; McCormick S; Small C; Zhang X; Zganiacz A; Aoki N; Xing Z
Infect Immun; 2007 May; 75(5):2244-52. PubMed ID: 17307945
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.
Derrick SC; Evering TH; Sambandamurthy VK; Jalapathy KV; Hsu T; Chen B; Chen M; Russell RG; Junqueira-Kipnis AP; Orme IM; Porcelli SA; Jacobs WR; Morris SL
Immunology; 2007 Feb; 120(2):192-206. PubMed ID: 17076705
[TBL] [Abstract][Full Text] [Related]
16. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
Ferraz JC; Stavropoulos E; Yang M; Coade S; Espitia C; Lowrie DB; Colston MJ; Tascon RE
Infect Immun; 2004 Dec; 72(12):6945-50. PubMed ID: 15557616
[TBL] [Abstract][Full Text] [Related]
17. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.
Santos Júnior RR; Sartori A; Bonato VL; Coelho Castelo AA; Vilella CA; Zollner RL; Silva CL
Clin Exp Immunol; 2007 Sep; 149(3):570-8. PubMed ID: 17590177
[TBL] [Abstract][Full Text] [Related]
18. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
19. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
[TBL] [Abstract][Full Text] [Related]
20. A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70.
Uto T; Tsujimura K; Uchijima M; Seto S; Nagata T; Suda T; Chida K; Nakamura H; Koide Y
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):189-96. PubMed ID: 21204994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
